Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03945357 · ClinicalTrials.gov registry record · Phase 3
Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)
A Phase 3 study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT03945357 is a Phase 3 study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 250 participants.
The verdict
NCT03945357, a Phase 3 study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
This is a study to determine if the incidence of infection at the Surgical SitE is impacted if with Antibiotic Irrigation is used during Ventral Hernia Repair (RINSE Trial)
Interventions
- DRUG Normal saline
- DRUG Gemcitabine/ clindamycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2023-01-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03945357
The ClinicalTrials.gov registry entry for NCT03945357 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT03945357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03945357 about?
NCT03945357 is a clinical study titled "Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)". This is a study to determine if the incidence of infection at the Surgical SitE is impacted if with Antibiotic Irrigation is used during Ventral Hernia Repair (RINSE Trial)
What is the current status of trial NCT03945357?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2019-05-15. Estimated completion is 2023-01-09.
What interventions are being tested in trial NCT03945357?
The interventions under investigation include: Normal saline (DRUG), Gemcitabine/ clindamycin (DRUG).
Who is sponsoring clinical trial NCT03945357?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.